Exploration of whether socioeconomic factors affect the results of priority setting partnerships: updating the top 10 research priorities for the management of Parkinson's in an international setting.
Biomedical Research; Health Priorities; Humans; Parkinson Disease/therapy; Prospective Studies; Socioeconomic Factors; Surveys and Questionnaires; neurology; parkinson-s disease; qualitative research; statistics & research methods
Résumé :
[en] OBJECTIVES: Explore whether socioeconomic differences of patients affect the prioritisation of pre-existing research questions and explore the agreement between healthcare professionals (HCP) and patients in priority setting partnerships (PSPs). DESIGN AND SETTING: Prospective, three centre survey across UK (400 participants), Tuebingen (176 participants) and Luxembourg (303 participants). People with Parkinson's (PwP), research participants, relatives and HCP associated with three Parkinson's cohort studies were invited to participate, along with linked centres (clinical care settings, research groups, charities). Responders were encouraged to pass on the survey to friends/families/carers. METHODS: The survey involved rating the importance of research questions on a Likert scale, allowing for the generation of one new question participants felt was particularly important. Collection of demographic information allowed for comparisons of priorities across a range of socioeconomic variables; the top 10 research priorities for each group were then compared. Questions added by participants were subject to a thematic analysis. RESULTS: 879 participants completed the survey (58% PwP, 22% family/friends, 13% HCP, 4% carers). Finding the best form of physiotherapy for PwP was the number one priority across the majority of analyses. HCP were the only subgroup not to place physiotherapy in the top 10. Factors most likely to affect prioritisation in PwP included educational level, presence of carer support and disease duration. There was little difference between other socioeconomic categories. CONCLUSIONS: Socioeconomic factors modestly influenced some research priority ratings but did not significantly affect the top priority in most comparisons. Future studies must ensure patients from a range of socioeconomic backgrounds are recruited, ensuring results generalisable to the public while also identifying any key disparities in prioritisation. PSP should also take care that HCP do not skew results during prioritisation of questions, as in this study the most important priority to patients was not identified by professionals.
Disciplines :
Neurologie
Auteur, co-auteur :
Bowring, Francesca
Welch, Jessica
Woodward, Charlotte
Lo, Christine
Lawton, Michael
Sulzer, Patricia
HANFF, Anne-Marie ; University of Luxembourg > Faculty of Science, Technology and Medecine (FSTM)
KRÜGER, Rejko ; University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Translational Neuroscience
Liepelt-Scarfone, Inga
Hu, Michele T.
Co-auteurs externes :
yes
Langue du document :
Anglais
Titre :
Exploration of whether socioeconomic factors affect the results of priority setting partnerships: updating the top 10 research priorities for the management of Parkinson's in an international setting.
Date de publication/diffusion :
2022
Titre du périodique :
BMJ Open
eISSN :
2044-6055
Maison d'édition :
BMJ Publishing Group, Royaume-Uni
Volume/Tome :
12
Fascicule/Saison :
6
Pagination :
e049530
Peer reviewed :
Peer reviewed vérifié par ORBi
Projet européen :
H2020 - 692320 - CENTRE-PD - TWINNING for a Comprehensive Clinical Centre for the Diagnosis and Treatment of Parkinson's Disease
Crowe S, Fenton M, Hall M, et al. Patients', clinicians' and the research communities' priorities for treatment research: there is an important mismatch. Res Involv Engagem 2015;1:2.
Tallon D, Chard J, Dieppe P. Relation between agendas of the research community and the research consumer. Lancet 2000;355:2037-40.
Ferner RE. The infuence of big pharma. BMJ 2005;330:855-6.
Smith R. Curbing the infuence of the drug industry: a British view. PLoS Med 2005;2:e241.
Lexchin J, Bero LA, Djulbegovic B, et al. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 2003;326:1167-70.
Allicance JL. The PSPs. Available: http://www.jla.nihr.ac.uk/priority-setting-partnerships/2018
Nature. com. Parkinson's disease-Latest research and news | Nature, 2019. Available: https://www.nature.com/subjects/parkinsons-disease
Aarsland D, Andersen K, Larsen J P, et al. The rate of cognitive decline in Parkinson disease. Arch Neurol 2004;61:1906-11.
Chaudhuri KR, Yates L, Martinez-Martin P. The non-motor symptom complex of Parkinson's disease: a comprehensive assessment is essential. Curr Neurol Neurosci Rep 2005;5:275-83.
Chaudhuri KR, Healy DG, Schapira AHV, et al. Non-Motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 2006;5:235-45.
De Pablo-Fernández E, Lees AJ, Holton JL, et al. Prognosis and neuropathologic correlation of clinical subtypes of Parkinson disease. JAMA Neurol 2019;76:470-9.
Jankovic J. Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 2008;79:368-76.
Rizek P, Kumar N, Jog MS. An update on the diagnosis and treatment of Parkinson disease. CMAJ 2016;188:1157-65.
Fereshtehnejad S-M, Romenets SR, Anang JBM. New clinical subtypes of Parkinson disease and their longitudinal progression: a prospective cohort comparison with other PhenotypesNew clinical subtypes of Parkinson DiseaseNew clinical subtypes of Parkinson disease. JAMA Neurology 2015;72:863-73.
Lawton M, Baig F, Rolinski M, et al. Parkinson's disease subtypes in the Oxford Parkinson disease centre (Opdc) discovery cohort. J Parkinsons Dis 2015;5:269-79.
Thenganatt MA, Jankovic J. Parkinson disease subtypes. JAMA Neurol 2014;71:499-504.
Lawton M, Ben-Shlomo Y, May MT, et al. Developing and validating Parkinson's disease subtypes and their motor and cognitive progression. J Neurol Neurosurg Psychiatry 2018;89:1279-87.
Deane KHO, Flaherty H, Daley DJ, et al. Priority setting partnership to identify the top 10 research priorities for the management of Parkinson's disease. BMJ Open 2014;4:e006434.
CENTRE-PD. What is CENTRE-PD? Available: https://www.centre-pd.lu/what-is-centre-pd2017 [Accessed 02 Feb 2020].
OPDC. Opdc publications. Available: https://www.opdc.ox.ac.uk/opdc-literature2020 [Accessed 19 Oct 2020].
Research HIfCB. The Department of neurodegenerative diseases publications. Available: https://www.hih-tuebingen.de/en/research/neurodegenerative-diseases/publications/2020 [Accessed 19 Oct 2020].
NCER-PD. Publications. Available: https://parkinson.lu/research-participation/publications2020 [Accessed 19 Oct 2020].
Hipp G, Vaillant M, Diederich NJ, et al. The Luxembourg Parkinson's study: a comprehensive approach for stratifcation and early diagnosis. Front Aging Neurosci 2018;10:326-26.
Szewczyk-Krolikowski K, Tomlinson P, Nithi K, et al. The infuence of age and gender on motor and non-motor features of early Parkinson's disease: initial fndings from the Oxford Parkinson disease center (Opdc) discovery cohort. Parkinsonism Relat Disord 2014;20:99-105.
World Health Organisation. Process of translation and adaptation of instruments, 2010. Available:/entity/substance-abuse/research-tools/translation/en/index.html
McHugh ML. Interrater reliability: the kappa statistic. Biochem Med 2012;22:276-82.
Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74.
Feeney S, Horan C. The Bologna Process and the European Qualifcations Framework: A Routines Approach to Understanding the Emeergence of Educational Policy Harmonisation-From Abstract Ideas to Policy Implementation. Policy Paradigms Theory Prac 2015:189-216.
Springate SD. The effect of sample size and bias on the reliability of estimates of error: a comparative study of Dahlberg's formula. Eur J Orthod 2012;34:158-63.
Tomlinson CL, Herd C P, Clarke CE. Physiotherapy for Parkinson's disease: a comparison of techniques. Cochrane Database of Systematic Reviews 2014;57.
Siciliano M, Trojano L, Santangelo G, et al. Fatigue in Parkinson's disease: a systematic review and meta-analysis. Mov Disord 2018;33:1712-23.
Allen NE, Schwarzel AK, Canning CG. Recurrent falls in Parkinson's disease: a systematic review. Parkinsons Dis 2013;2013:906274.
Verschuur CVM, Suwijn SR, Post B, et al. Protocol of a randomised delayed-start double-blind placebo-controlled multi-centre trial for levodopa in early Parkinson's disease: the LEAP-study. BMC Neurol 2015;15:236.
Connolly BS, Lang AE. Pharmacological treatment of Parkinson disease: a review. JAMA 2014;311:1670-83.
Bjelland I, Krokstad S, Mykletun A, et al. Does a higher educational level protect against anxiety and depression? the HUNT study. Soc Sci Med 2008;66:1334-45.
Jansen T, Rademakers J, Waverijn G, et al. The role of health literacy in explaining the association between educational attainment and the use of out-of-hours primary care services in chronically ill people: a survey study. BMC Health Serv Res 2018;18:394.